Stefano Serpelloni

Mr. Stefano Serpelloni

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
FPfrancesca Paradiso
francesca Paradiso
SSStefano Serpelloni
Stefano Serpelloni
LFLewis Francis
Lewis Francis
FTFrancesca Taraballi
Francesca Taraballi
From the development of self-aggregating, scaffold-free multicellular spheroids to the inclusion of scaffold systems, 3D models have progressively increased in complexity to better mimic native tissues. The inclusion of a third dimension in cancer models allows researchers to zoom out from a significant but limited cancer cell research approach to a wider investigation of the tumor microenvironment. This model can include multiple cell types and many elements from the extracellular matrix (ECM), which provides mechanical support for the tissue, mediates cell-microenvironment interactions, and plays a key role in cancer cell invasion. Both biochemical and biophysical signals from the extracellular space strongly influence cell fate, the epigenetic landscape, and gene expression. Specifically, a detailed mechanistic understanding of tumor cell-ECM interactions, especially during cancer invasion, is lacking. In this review, we focus on the latest achievements in the study of ECM biomechanics and mechanosensing in cancer on 3D scaffold-based and scaffold-free models, focusing on each platform’s level of complexity, up-to-date mechanical tests performed, limitations, and potential for further improvements.

23 April 2023 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
KHKatharine D. Harper
Katharine D. Harper
KPKwan J. Park
Kwan J. Park
ABAva A. Brozovich
Ava A. Brozovich
TSThomas C. Sullivan
Thomas C. Sullivan
SSStefano Serpelloni
Stefano Serpelloni
TCTerry A. Clyburn
Terry A. Clyburn

8 March 2024 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
AWAustin E. Wininger
Austin E. Wininger
PGPradyumna Gurusamy
Pradyumna Gurusamy
TSThomas C. Sullivan
Thomas C. Sullivan
SSStefano Serpelloni
Stefano Serpelloni
FTFrancesca Taraballi
Francesca Taraballi
TBTimothy S. Brown
Timothy S. Brown

1 February 2022 in Fibers
Verified
Journal Article
Open access
PDF file
EHEmma He
Emma He
SSStefano Serpelloni
Stefano Serpelloni
PAPhillip Alvear
Phillip Alvear
MRMaham Rahimi
Maham Rahimi
FTFrancesca Taraballi
Francesca Taraballi
Vascular disease in elderly patients is a growing health concern, with an estimated prevalence of 15–20% in patients above 70 years old. Current treatment for vascular diseases requires the use of a vascular graft (VG) to revascularize lower or upper extremities, create dialysis access, treat aortic aneurysms, and repair dissection. However, postoperative infection is a major complication associated with the use of these VG, often necessitating several operations to achieve complete or partial graft excision, vascular coverage, and extra-anatomical revascularization. There is also a high risk of morbidity, mortality, and limb loss. Therefore, it is important to develop a method to prevent or reduce the incidence of these infections. Numerous studies have investigated the efficacy of antibiotic- and antiseptic-impregnated grafts. In comparison to these traditional methods of creating antimicrobial grafts, nanotechnology enables researchers to design more efficient VG. Nanofibers and nanoparticles have a greater surface area compared to bulk materials, allowing for more efficient encapsulation of antibiotics and better control over their temporo-spatial release. The disruptive potential of nanofibers and nanoparticles is exceptional, and they could pave the way for a new generation of prosthetic VG. This review aims to discuss how nanotechnology is shaping the future of cardiovascular-related infection management.

12 April 2021
Verified
Conference Paper
Open access
PDF file
PSP. Alex Smith
P. Alex Smith
TKTimothy J. Keane
Timothy J. Keane
SSStefano Serpelloni
Stefano Serpelloni
SRStephen G. Ramon
Stephen G. Ramon
FTFrancesca Taraballi
Francesca Taraballi
Postoperative adhesions are scar tissue that form between internal organs after surgery, leading to devastating life-long complications. Current adhesion barriers used clinically are solid sheets which can only be applied in open surgeries through large incisions. We have developed a material which can be applied as a liquid in minimally invasive surgeries which transitions into a solid thin film barrier upon contact with warm tissue. However, to be effective, it must be sprayed, and spraying a viscous liquid consistently is challenging. We proposed using a gas dispersant to facilitate aerosolization. In this study, we compared a commercially available nozzle without gas dispersant to a custom 3D printed nozzle with gas dispersant. For comparison, we measured both spray pattern and stiffness of the resulting gel. We found that when sprayed with gas dispersant, the spray pattern covered a larger area, and the resulting gel was stiffer than when sprayed without gas dispersant.